Buspirone Hydrochloride Tablet
Product Images NDC 16729-202

8 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 16729-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buspirone Structural Formula (Buspirone Str)

Buspirone Structural Formula (Buspirone Str)
Chemical structure of buspirone hydrochloride depicted as a molecular diagram with atoms and bonds, showing key functional groups and the HCl component.*
FDA Label Image

Dosage Table (Buspirone Fig 1)

Dosage Table (Buspirone Fig 1)
An instructional diagram showing how to split Buspirone Hydrochloride tablets to achieve specific doses when prescribed 15 mg or 30 mg tablets. It displays the tablet scored and the resulting doses for whole tablets, halves, and thirds to guide correct dosing.*
FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

Quadrisect Photo (Buspirone Fig 2)
An instructional illustration showing how to identify and handle Buspirone Hydrochloride tablets of 15 mg and 30 mg strengths. The left panel depicts a 15 mg tablet marked 'B M 4' being held between two fingers. The right panel shows a 30 mg tablet marked 'B 8' also held by two fingers. Labels under each panel indicate the respective tablet strengths.*
FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 5mg 100)

Buspirone Hydrochloride Tablets (Buspirone 5mg 100)
Buspirone Hydrochloride Tablets, USP 5 mg oral tablets packaging label from Accord Healthcare Inc. The label includes dosage strength, storage instructions, prescription-only status, dispensing instructions, manufacturer details (Intas Pharmaceuticals Limited, India), and shows the package contains 100 tablets. Barcodes and NDC code 16729-200 are visible.*
FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 7pt5mg 100)

Buspirone Hydrochloride Tablets (Buspirone 7pt5mg 100)
BusPIRone Hydrochloride Tablets USP 7.5 mg oral tablets label from Accord Healthcare Inc. The label shows dosage strength as 7.5 mg, directions to keep out of reach of children, storage instructions, and a count of 100 tablets. Manufactured by Intas Pharmaceuticals Limited, India. It includes a barcode and NDC 16729-201-01.*
FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 10mg 100)

Buspirone Hydrochloride Tablets (Buspirone 10mg 100)
BusPIRone Hydrochloride Tablets USP 10 mg oral tablet label from Accord Healthcare Inc. This packaging label includes dosage strength 10 mg, prescription status (Rx only), NDC 16729-202-01, barcode, and storage instructions. The label also advises dispensing with a patient information leaflet and indicates a count of 100 tablets.*
FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 15mg 100)

Buspirone Hydrochloride Tablets (Buspirone 15mg 100)
Label for Buspirone Hydrochloride Tablets USP 15 mg by Accord Healthcare Inc. The oral tablet packaging indicates it contains 100 tablets, with the NDC number 16729-203-01. The label includes storage instructions, a note to dispense with patient information leaflet, and child-resistant packaging warnings. The design features purple and orange accents with barcodes and manufacturer details.*
FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 30mg 100)

Buspirone Hydrochloride Tablets (Buspirone 30mg 100)
The label shows BusPIRone Hydrochloride Tablets, USP 30 mg oral tablets by Accord Healthcare Inc. The package contains 100 tablets. It includes storage instructions at 25°C with allowed excursions between 15°C to 30°C, a reminder for pharmacists to dispense with patient information leaflets, and manufacturing details by Intas Pharmaceuticals Limited, India. The label also displays NDC 16729-289-01 and barcode images.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.